
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Artemis 2 astronauts reveal adorable zero-g indicator 'Rise' | Space photo of the day for March 31, 2026 - 2
Tech for Efficiency: Applications and Apparatuses to Accomplish More - 3
Your kid wants it now. What saying yes, no or not yet teaches kids about money and instant gratification. - 4
Images of Bangladeshi motorcyclists sleeping at petrol pumps are AI-generated - 5
Al-Sharaa denies he called for 80% of Syrians to return from Germany
The Best Internet Mastering Stages for Expertise Improvement
Like many holiday traditions, lighting candles and fireplaces is best done in moderation
Smooth out Your Funds: Cash The board Simplified
Make your choice for the sweet that transports you to its nation of beginning!
Understanding Preschool Projects: An Extensive Aide
Astronauts welcome arrival of new crewmates | On the International Space Station this week Nov. 24-28, 2025
Figure out How to Adjust Work, Life, and an Internet based Degree
Scaling New Levels: Rock Climbing Spots On the planet
Home Security Frameworks with Shrewd Elements













